Literature DB >> 12914781

Activation of CFTR by genistein in human airway epithelial cell lines.

Charlotte Andersson1, Zhanna Servetnyk, Godfried M Roomans.   

Abstract

Cystic fibrosis (CF) is caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel expressed in epithelial cells. The effects of genistein and 4-phenylbutyrate (PBA) on CFTR were studied in three human airway epithelial cell lines expressing wild-type or DeltaF508 CFTR: Calu-3, CFSMEo-, and CFBE41o- cells. The cells were loaded with the fluorescent dye N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bromide (MQAE) and chloride efflux was studied. Forskolin and 3-isobutyl-1-methylxanthine (IBMX) induced chloride efflux in Calu-3 cells but not in CF lines. Genistein (2.5-50 microM) alone was able to induce chloride efflux in all cell lines. Genistein did not enhance the effect of forskolin and IBMX. PBA had little or no effect on genistein-induced chloride efflux. The effect of genistein seen at low concentrations makes genistein interesting for possible pharmacological treatment of CF, since it is known that similar concentrations can be obtained in plasma by a soy-rich diet.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914781     DOI: 10.1016/s0006-291x(03)01436-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

Authors:  Xuehong Liu; Nicolette O'Donnell; Allison Landstrom; William R Skach; David C Dawson
Journal:  Biochemistry       Date:  2012-06-15       Impact factor: 3.162

2.  Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5).

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Stephen B Hladky; Suresh V Ambudkar; Margery A Barrand
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

3.  Curcumin and genistein additively potentiate G551D-CFTR.

Authors:  Ying-Chun Yu; Haruna Miki; Yumi Nakamura; Akiko Hanyuda; Yohei Matsuzaki; Yoichiro Abe; Masato Yasui; Kazuhiko Tanaka; Tzyh-Chang Hwang; Silvia G Bompadre; Yoshiro Sohma
Journal:  J Cyst Fibros       Date:  2011-03-26       Impact factor: 5.482

4.  Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers.

Authors:  Zsuzsa Bebok; James F Collawn; John Wakefield; William Parker; Yao Li; Karoly Varga; Eric J Sorscher; J P Clancy
Journal:  J Physiol       Date:  2005-10-06       Impact factor: 5.182

Review 5.  Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation.

Authors:  Kelvin D MacDonald; Karen R McKenzie; Pamela L Zeitlin
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Prostaglandin E2 induces chloride secretion through crosstalk between cAMP and calcium signaling in mouse inner medullary collecting duct cells.

Authors:  Madhumitha Rajagopal; Sheela V Thomas; Paru P Kathpalia; Yu Chen; Alan C Pao
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-27       Impact factor: 4.249

Review 7.  Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications.

Authors:  Yoshiro Sohma; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Differential activation of the HCO(3)(-) conductance through the cystic fibrosis transmembrane conductance regulator anion channel by genistein and forskolin in murine duodenum.

Authors:  Biguang Tuo; Guorong Wen; Ursula Seidler
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Cellular chloride and bicarbonate retention alters intracellular pH regulation in Cftr KO crypt epithelium.

Authors:  Nancy M Walker; Jinghua Liu; Sydney R Stein; Casey D Stefanski; Ashlee M Strubberg; Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-05       Impact factor: 4.052

Review 10.  Clinical and experimental applications of sodium phenylbutyrate.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Drugs R D       Date:  2011-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.